Bioequivalencia de una formulación nacional de Ambroxol
Objectives: To assess the relative bioavailability of two oral formulations of ambroxol commercialized in Chile, a generic syrup and the original product, MucosolvanR from Boehringer Ingelheim. Methods: A randomized, cross-over and double blind study was performed in twelve healthy volunteers who re...
Enregistré dans:
Auteurs principaux: | SAAVEDRA S.,IVÁN, GAETE G.,LEONARDO, CARRILLO C.,MITZY, ORTIZ O.,MARIO, ÁVILA C.,LUIS, LEYTON M,SANTIAGO, ROJAS G.,LILA, GALLARDO M,NICOLÁS, MUÑOZ B.,FERNANDO, SALDAÑA V.,ADIELA |
---|---|
Langue: | Spanish / Castilian |
Publié: |
Sociedad Chilena de Enfermedades Respiratorias
2003
|
Sujets: | |
Accès en ligne: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-73482003000100004 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Bioequivalencia entre dos formulaciones de claritromicina comprimidos de liberación modificada existentes en el mercado chileno
par: GAETE G,LEONARDO, et autres
Publié: (2003) -
Bioequivalencia entre dos formulaciones de claritromicina en suspensión pediátrica existentes en el mercado chileno
par: GAETE G,LEONARDO, et autres
Publié: (2003) -
Thermo-Analytical and Compatibility Study with Mechanistic Explanation of Degradation Kinetics of Ambroxol Hydrochloride Tablets under Non-Isothermal Conditions
par: Dijana Jelić, et autres
Publié: (2021) -
Pulmonary-Affinity Paclitaxel Polymer Micelles in Response to Biological Functions of Ambroxol Enhance Therapeutic Effect on Lung Cancer
par: He W, et autres
Publié: (2020) -
A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension
par: Li Y, et autres
Publié: (2018)